TY  - JOUR

T1  - MP-08.24: Zoledronic acid-mediated normalization of NTX levels correlates with increased clinical benefits in patients with bone metastases secondary to prostate cancer

JO  - Urology

PY  - 2007/09/02

AU  - Saad F

AU  - Lipton A

AU  - Coleman R

ED  - 

DO  - DOI: 10.1016/j.urology.2007.06.328

PB  - Elsevier BV

VL  - 70

IS  - 3

SP  - 84

EP  - 85

Y2  - 2025/10/10

ER  -